ArticleOPEN ACCESS

Focus on Immune Checkpoint Inhibitors-related Intestinal Inflammation: From Pathogenesis to Therapeutical Approach

Inflammatory Bowel Diseases
DOI: 10.1093/ibd/izad229
10Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Immune checkpoint inhibitors (ICIs)-induced colitis is the most widely reported immune-related adverse event following the use of ICIs. In this review, we comprehensively discuss current evidence regarding pathogenesis, diagnosis, and management of ICIs-induced colitis, including a focus on innovative therapies.

Author supplied keywords

Cite

CITATION STYLE

APA

Gaudio, A. D., Di Vincenzo, F., Petito, V., Giustiniani, M. C., Gasbarrini, A., Scaldaferri, F., & Lopetuso, L. R. (2024, June 1). Focus on Immune Checkpoint Inhibitors-related Intestinal Inflammation: From Pathogenesis to Therapeutical Approach. Inflammatory Bowel Diseases. Oxford University Press. https://doi.org/10.1093/ibd/izad229

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free